67 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Disease in HIV-AIDS ... #Prophylaxis #Opportunistic ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Disease in HIV-AIDS ... #Prophylaxis #Opportunistic ... #HIVAIDS #IDSA ... #management #pharmacology
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Initiation of ART in HIV ... Infections • ... of starting OI treatment ... #Opportunistic ... #Infections #management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Genital Herpes Simplex - CDC 2021 Treatment Guidelines
Recommended Regimens:
 • First clinical episode of genital herpes
Simplex - CDC 2021 Treatment ... Regimens: • First clinical ... with HIV infection ... #CDC #CDC2021 #Treatment ... #Guidelines #Management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... Clostridium difficile Infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
hepatitis C virus (HCV ... ) infection. ... DAAs #Antivirals #table ... #treatment #hcv ... HepC #HepatitisC #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
) Infections in ... • Continue treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS